Completed

NCT Number: NCT04205201

The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

Outpatient department of cmch, ceitc,cimch POAG patients enrolled for the study.

Completed

Looking for future studies?

Key information

Conditions

To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Facuity of basic science and para clinical science, Dhaka, Chittagong, Bangladesh

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

IOP 22_34mmof Hg,newly diagnosed case, bilateral POAG patients Patients.

Exclusion criteria

pregnant and lactating women, infection, any eye surgery.

Treatment and study plan

Drugs, Investigational

Drug

To see the safety and efficacy of topical latanoprost compared with topical brimonidine in the treatment of the primary open angle

Other names: Brimonidine

Primary outcomes

More than 20% IOP reduction

Time frame: 0_3 months

From baseline to month 3

Secondary outcomes

Adverse reaction

Time frame: O_3 months

Record every follow up period baseline to month 3.

Sponsors and collaborators

Lead sponsor

Chittagong Medical College

Other

Registry information

Important dates

Study start: 2018
Primary completion: 2019
Study completion: 2019
First posted: Dec 19, 2019
Registry last updated: Dec 26, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.